CytoDyn files pivotal trial protocol for HIV monotherapy with FDA
CytoDyn announced it has filed with the FDA the pivotal trial protocol for leronlimab as a monotherapy for HIV patients. The latest investigative monotherapy trial for HIV has now produced sufficient data for the Company’s Key Opinion Leaders to design a monotherapy pivotal Phase 3 trial. May 15, 2019